Governance
Corporate Governance, Transparency, and Accountability
Kaster Medical Technology believes in transparent and responsible governance as the foundation of its operations. Our corporate governance model aims to ensure clarity in decision-making processes, fairness in relationships with stakeholders, employees, and customers, and regulatory compliance.
We are committed to ensuring that every corporate action—strategic, operational, or administrative—respects ethical values, responsibility, and integrity. Our governance structure reflects our commitment to legality, safety, quality, and inclusion.
CORPORATE COMPLIANCE MODEL AND CODE OF ETHICS (Legislative Decree No. 231/2001)
To ensure maximum regulatory compliance and prevent the risk of administrative liability, Kaster has adopted an Organizational, Management, and Control Model in accordance with Legislative Decree 231/2001.
What this means in concrete terms::
- Adoption of a Code of Ethics that defines principles of conduct, transparency, responsibility, and internal rules that all employees and managers must observe.
- Establishment of an independent supervisory unit (Supervisory Body - SB) responsible for monitoring compliance with the model, reporting any non-compliance, and ensuring the effectiveness of procedures.
- Internal procedures and controls designed to prevent predicate offenses (corruption, fraud, environmental or health and safety violations, administrative fraud, computer crimes, etc.) that could expose the organization to sanctions.
- Commitment to keeping the model constantly updated, integrating compliance policies, whistleblowing systems, training, and awareness-raising.
CODE OF ETHICS
SURVEILLANCE BODY
WHISTLE BLOWING
This system is an integral part of our governance: it ensures that every decision—from procurement to delivery, from technical assistance to training—follows rigorous and transparent standards.
Certified Quality and Standards
The quality of our processes, services, and medical supplies is a fundamental pillar for Kaster. Therefore, we have implemented an ISO 9001 -compliant quality management system, which guides our internal procedures and ensures an ongoing commitment to excellence.
The key points of our quality approach:
- Quality policy focused on customer satisfaction, regulatory compliance, and continuous improvement.
- Document management and process traceability: definition of the scope of the management system, quality objectives, supplier selection criteria, training and control records, and internal audits.
- Commitment to periodic process review and continuous improvement: performance monitoring, risk analysis, and corrective actions to consistently ensure high levels of service and safety.
Gender Equality, Ethics, and Inclusion
Kaster is committed to promoting diversity, equity, and inclusion within its team and in all relationships with stakeholders and partners. For this reason, it has integrated a Gender Equality Management System into its quality system, in compliance with the standard.
We firmly believe that gender and background diversity represents not only a social but also a professional asset, capable of strengthening creativity, balance, and the quality of work.
We foster an internal culture based on merit, mutual respect, and equal opportunity.
We guarantee fairness in our selection, hiring, professional development, and compensation policies, without any gender or ethnic discrimination.
We promote training and awareness initiatives to foster a culture of inclusion and respect.
This approach reflects our commitment to a more humane, responsible, and aware company.
- Summary of the methodology used: KASTER S.r.l. discloses the amount of transfers of value as a net amount, expressed in euros, excluding VAT and gross of income taxes payable by the recipient; KASTER S.r.l. applies the accrual basis of accounting to prepare its financial statements.
Transparency
In compliance with the provisions of the Confindustria Medical Devices Code of Ethics, KASTER S.r.l. publishes reports on transfers of value made during each yearto Healthcare Professionals, Healthcare Organizations, and Third Parties within the first six months of the following year.
The data is published:
- on an individual basis, for transfers of value to Healthcare Organizations and Third Parties, as indicated in Article 4.4 of the Confindustria Medical Devices Code of Ethics
- on an individual basis, for transfers of value to Healthcare Professionals who have given consent, as indicated in Article 4.3 of the Confindustria Medical Devices Code of Ethics
- on an aggregate basis, for the transfers of value indicated in point 2) above, if the Healthcare Professionals have not given consent to publication on an individual basis
- on an aggregate basis, for the transfers of value indicated in Article 4.5 of the Confindustria Medical Devices Code of Ethics